FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1754869596> ?p ?o ?g. }

• W1754869596 endingPage "864" @default.
• W1754869596 startingPage "851" @default.
• W1754869596 abstract "In the current study, the prognostic and predictive values of serum transforming growth factor-β1 (TGF-β1), insulin-like growth factor I (IGF-I)/IGF-I receptor (IGF-IR) and vascular endothelial growth factor-A (VEGF-A) were evaluated in triple-negative and non-triple-negative breast cancer (TNBC and non-TNBC). The aim was to identify a group of serological biomarkers and to identify possible candidates for targeted therapy in patients with TNBC and non-TNBC. Protein levels of TGF-β1, IGF-I/IGF-IR and VEGF-A in the serum were measured in 43 TNBC, 53 non‑TNBC and 20 normal control participants using quantitative ELISA assays. Results were correlated against standard prognostic factors, response to treatment and survival. TNBC was identified to be associated with poor prognosis and serum levels of VEGF-A and IGF/IGF-IR were significantly higher in the TNBC group compared with the non-TNBC group. IGF-IR and VEGF-A overexpression was observed to be correlated with TGF-β1 expression and all of the markers investigated were associated with metastasis and disease progression. In the multivariate analysis, VEGF-A, IGF-I and IGF-IR were observed to be independent predictors for overall survival, whereas TGF-β1 and lymph node status were identified as independent predictors for disease-free survival. The overall response rate was significantly lower in patients with TNBC and those with high levels of TGF-β1, IGF-I/IGF-IR and VEGF-A. In view of the present results, it was concluded that TGF-β1, IGF-I/IGF-IR and VEGF-A overexpression is associated with the presence of aggressive tumors, which exhibit an increased probability of metastasis, a poor response to treatment and reduced survival rate. This indicates that VEGF-A, IGF-IR and IGF-I have the potential to be used as surrogate biomarkers and are promising candidates for targeted therapy, particularly in patients with TNBC." @default.
• W1754869596 created "2016-06-24" @default.
• W1754869596 creator A5013982633 @default.
• W1754869596 creator A5029567388 @default.
• W1754869596 creator A5039635084 @default.
• W1754869596 creator A5040498831 @default.
• W1754869596 creator A5047078549 @default.
• W1754869596 creator A5079570684 @default.
• W1754869596 creator A5091471389 @default.
• W1754869596 date "2015-03-27" @default.
• W1754869596 modified "2023-10-12" @default.
• W1754869596 title "Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer" @default.
• W1754869596 cites W131031273 @default.
• W1754869596 cites W1565276921 @default.
• W1754869596 cites W1906211198 @default.
• W1754869596 cites W1930849536 @default.
• W1754869596 cites W1963888992 @default.
• W1754869596 cites W1965751280 @default.
• W1754869596 cites W1971584425 @default.
• W1754869596 cites W1978150117 @default.
• W1754869596 cites W1994737622 @default.
• W1754869596 cites W1995673324 @default.
• W1754869596 cites W1998961381 @default.
• W1754869596 cites W2003385907 @default.
• W1754869596 cites W2007278291 @default.
• W1754869596 cites W2007747524 @default.
• W1754869596 cites W2014584180 @default.
• W1754869596 cites W2030083110 @default.
• W1754869596 cites W2031770999 @default.
• W1754869596 cites W2033079375 @default.
• W1754869596 cites W2038573658 @default.
• W1754869596 cites W2041154504 @default.
• W1754869596 cites W2048654496 @default.
• W1754869596 cites W2057418848 @default.
• W1754869596 cites W2058297837 @default.
• W1754869596 cites W2063361476 @default.
• W1754869596 cites W2065351002 @default.
• W1754869596 cites W2067658687 @default.
• W1754869596 cites W2069653040 @default.
• W1754869596 cites W2071040328 @default.
• W1754869596 cites W2076668534 @default.
• W1754869596 cites W2079113033 @default.
• W1754869596 cites W2079203759 @default.
• W1754869596 cites W2079263525 @default.
• W1754869596 cites W2080886948 @default.
• W1754869596 cites W2083713591 @default.
• W1754869596 cites W2086286077 @default.
• W1754869596 cites W2096662041 @default.
• W1754869596 cites W2100904827 @default.
• W1754869596 cites W2112687290 @default.
• W1754869596 cites W2113402231 @default.
• W1754869596 cites W2114426106 @default.
• W1754869596 cites W2116403488 @default.
• W1754869596 cites W2118605519 @default.
• W1754869596 cites W2118826846 @default.
• W1754869596 cites W2120512382 @default.
• W1754869596 cites W2124128113 @default.
• W1754869596 cites W2124281312 @default.
• W1754869596 cites W2128098778 @default.
• W1754869596 cites W2139248078 @default.
• W1754869596 cites W2140905796 @default.
• W1754869596 cites W2143659344 @default.
• W1754869596 cites W2151055760 @default.
• W1754869596 cites W2157555357 @default.
• W1754869596 cites W2157840751 @default.
• W1754869596 cites W2161415513 @default.
• W1754869596 cites W2161688555 @default.
• W1754869596 cites W2170602872 @default.
• W1754869596 cites W2322168524 @default.
• W1754869596 cites W2418186096 @default.
• W1754869596 cites W3024117005 @default.
• W1754869596 cites W4235005489 @default.
• W1754869596 cites W4240695995 @default.
• W1754869596 doi "https://doi.org/10.3892/mmr.2015.3560" @default.
• W1754869596 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4438878" @default.
• W1754869596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25824321" @default.
• W1754869596 hasPublicationYear "2015" @default.
• W1754869596 type Work @default.
• W1754869596 sameAs 1754869596 @default.
• W1754869596 citedByCount "44" @default.
• W1754869596 countsByYear W17548695962015 @default.
• W1754869596 countsByYear W17548695962016 @default.
• W1754869596 countsByYear W17548695962017 @default.
• W1754869596 countsByYear W17548695962018 @default.
• W1754869596 countsByYear W17548695962019 @default.
• W1754869596 countsByYear W17548695962020 @default.
• W1754869596 countsByYear W17548695962021 @default.
• W1754869596 countsByYear W17548695962022 @default.
• W1754869596 countsByYear W17548695962023 @default.
• W1754869596 crossrefType "journal-article" @default.
• W1754869596 hasAuthorship W1754869596A5013982633 @default.
• W1754869596 hasAuthorship W1754869596A5029567388 @default.
• W1754869596 hasAuthorship W1754869596A5039635084 @default.
• W1754869596 hasAuthorship W1754869596A5040498831 @default.
• W1754869596 hasAuthorship W1754869596A5047078549 @default.
• W1754869596 hasAuthorship W1754869596A5079570684 @default.
• W1754869596 hasAuthorship W1754869596A5091471389 @default.
• W1754869596 hasBestOaLocation W17548695961 @default.

• next